Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
David SandersCoherus BiosciencesCovered position: Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)27 filingsthrough 2026
Thomas WhartonInlet StrategiesCovered position: Legislative Assistant. Senator Lieberman May 2011-June 2012 Senior Legislative Assistant. Representative Dan Boren. July 2008-June 201118 filingsthrough 2026
Brian SutterCapitol Hill Consulting GroupCovered position: Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'0217 filingsthrough 2023
The filings
The 20 most recent of 78 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: coherus-biosciences-inc.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
24 filings
$3.4M on those filings
Pharmacy
PHA
8 filings
$340K on those filings
Budget/Appropriations
BUD
7 filings
$840K on those filings
Copyright/Patent/Trademark
CPT
7 filings
$840K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
BIOSIM Act
7 filingsthrough 2022
H.R. 2869117th CongressIncreasing Access to Biosimilars Act of 20217 filingsthrough 2022
S. 1176117th CongressOnshoring Essential Antibiotics Act7 filingsthrough 2022
S. 1427117th CongressIncreasing Access to Biosimilars Act of 20217 filingsthrough 2022
S. 1693117th CongressMedical Supplies for Pandemics Act of 20217 filingsthrough 2022
S. 3311118th CongressAmerican Made Pharmaceuticals Act of 20236 filingsthrough 2024
H.R. 2855117th CongressStar Rating for Biosimilars Act6 filingsthrough 2022
S. 2662117th CongressIndustrial Finance Corporation Act6 filingsthrough 2022
S. 1339118th CongressPharmacy Benefit Manager Reform Act5 filingsthrough 2024
H.R. 7400117th CongressAmerican Made Pharmaceuticals Act of 20225 filingsthrough 2022
S. 3991117th CongressAmerican Made Pharmaceuticals Act of 20225 filingsthrough 2022
S. 164117th CongressAdvancing Education on Biosimilars Act of 20213 filingsthrough 2021
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Emily Elizabeth Wilkinson-HollandCapitol Hill Consulting GroupCovered position: Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)17 filingsthrough 2023
Ben KenneyCoherus BiosciencesCovered position: Director of Strategic Communications and External Affairs, Centers for Medicare and Medicaid Services (2018-2021), Associate Administrator, General Services Administration (2017-2018), Legislative Aide, U.S. Sen. Daniel R. Coats (2011-2012)15 filingsthrough 2024
Michael ParkAlston & Bird LLPCovered position: Health Policy Counsel, Senate Finance Committee14 filingsthrough 2024
Jane LucasAlston & Bird LLPCovered position: Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD).14 filingsthrough 2024
Thomas WhartonCapitol Hill Consulting GroupCovered position: Health Legislative Assistant - Senator Joe Lieberman. May 2011 - June 2012 Senior Legislative Assistant - Congressman Dan Boren. July 2008 - June 201111 filingsthrough 2022
Robert SigginsAlston & Bird LLPCovered position: Chief of Staff, U.S. Rep. Earl Pomeroy.10 filingsthrough 2024
Ali McbrideCoherus Biosciences8 filingsthrough 2024
Earl PomeroyAlston & Bird LLPCovered position: Congressman, U.S. House of Representatives7 filingsthrough 2024
Christopher DavisCapitol Hill Consulting GroupCovered position: Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011).6 filingsthrough 2023
Mark RayderAlston & Bird LLPCovered position: LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo.5 filingsthrough 2024
Emily A ShawAlston & Bird LLP5 filingsthrough 2022
Kendra WhartonInlet StrategiesCovered position: Associate Deputy Attorney General, United States Department of Justice. January 2025 - July 2005: Legislative Aide, Senator Mitch McConnell. May 2008 - November 20124 filingsthrough 2026
Covered positions · 13 of 17 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
